As with most cancers, survival for Hodgkin lymphoma is improving. Some of the increase is likely to be attributable to changes in the diagnosis, classification and registration of Hodgkin lymphoma, so interpretation of these trends should be undertaken with caution.
One-year
Hodgkin Lymphoma (C81), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five- and ten-year survival has increased by an even greater amount than one-year survival since the early 1970s. Five-year age-standardised net survival for Hodgkin lymphoma in men has increased from 54% during 1971-1972 to a predicted survival of 84% during 2010-2011 in England and Wales – an absolute survival difference of 30 percentage points.[1] In women, five-year survival has increased from 59% to 86% over the same time period (a difference of 27 percentage points).
Hodgkin Lymphoma (C81), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Five-year survival for 2010-2011 is predicted using an excess hazard statistical model
Ten-year age-standardised net survival for Hodgkin lymphoma in men has increased from 45% during 1971-1972 to a predicted survival of 79% during 2010-2011 in England and Wales – an absolute survival difference of 34 percentage points.[1] In women, ten-year survival has increased from 51% to 83% over the same time period (a difference of 32 percentage points). Overall, 8 in 10 people diagnosed with Hodgkin lymphoma today are predicted to survive their disease for at least ten years.
Hodgkin Lymphoma (C81), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011
Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model
About this data
Data is for: England and Wales, 1971-2011, ICD-10 C81